Saturday, November 29, 2003

New Expensive Drugs no better than Old Inexpensive Drugs

As seen in the New Hampshire Telegraph

An older, inexpensive drug is as effective/ineffective at treating the symptoms of schizophrenia as a newer, more popular drug that costs about 100 times more, according to a new report. The study, published in Wednesday’s issue of the Journal of the American Medical Association, also found no difference in quality of life between those given the newer drug, olanzapine, and those given the older drug, haloperidol, plus another drug to control side effects. Haloperidol treatment was $3,000 to $9,000 cheaper per patient in annual costs, depending on how expenses were measured.

So we see that the major advantage to the newer drugs is their benefit to the corporate profit margin.

No comments: